Jupiter Topco LLC Takes $550.46 Million Position in Teleflex Incorporated $TFX

Jupiter Topco LLC bought a new stake in Teleflex Incorporated (NYSE:TFX) during the second quarter, HoldingsChannel reports. The firm bought 4,342,512 shares of the medical technology company’s stock, valued at approximately $550,456,000. Jupiter Topco LLC owned about 0.10% of Teleflex at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of TFX. Hsbc Holdings PLC boosted its position in Teleflex by 4.7% during the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after purchasing an additional 84 shares during the last quarter. Banque Cantonale Vaudoise raised its stake in shares of Teleflex by 82.5% during the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares in the last quarter. Hantz Financial Services Inc. raised its stake in shares of Teleflex by 40.5% during the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock worth $48,000 after purchasing an additional 113 shares in the last quarter. UMB Bank n.a. boosted its holdings in shares of Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after buying an additional 113 shares during the last quarter. Finally, Maryland State Retirement & Pension System boosted its holdings in shares of Teleflex by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after buying an additional 129 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. Piper Sandler restated an “overweight” rating and set a $169.00 target price (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research note on Wednesday, June 24th. Raymond James Financial reissued an “outperform” rating and issued a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. BMO Capital Markets initiated coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 price objective on the stock. Finally, Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $135.00 to $155.00 in a report on Friday, May 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Teleflex currently has a consensus rating of “Hold” and a consensus target price of $152.90.

Teleflex Stock Up 1.3%

TFX stock opened at $140.07 on Wednesday. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $145.00. The business’s 50 day simple moving average is $133.11 and its 200 day simple moving average is $125.37. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $5.93 billion, a PE ratio of -6.01, a PEG ratio of 0.92 and a beta of 0.81.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The business had revenue of $570.33 million during the quarter, compared to the consensus estimate of $559.59 million. During the same quarter last year, the firm posted $3.73 EPS. The company’s quarterly revenue was up 28.9% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, research analysts anticipate that Teleflex Incorporated will post 7.26 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s dividend payout ratio (DPR) is currently -5.84%.

Teleflex Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.